DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, today announced the company will participate in the upcoming ...
BALTIMORE and PALO ALTO, Calif., Dec. 2, 2024 /PRNewswire/ -- Today, DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback